Abstract
Several epidemiological studies, cross-sectional [1–3] and longitudinal [1, 4–6], have shown that obesity and hypertension are two directly related pathological disorders at any age [1, 7], and the overweight condition is a predicting and predisposing factor for future development of elevated systolic and diastolic pressures [4–6]. More recent studies, however, have concluded that in determining the risk profile of obese subjects, assessment of body fat distribution is important [8–11]. Thus, considerably evidence suggests that fat distribution is a relatively constant characteristic of human beings, even after major weight changes [8, 9]. By a variety of techniques, such as skinfold thickness measurements [10], circumference measurements [10–12], and computed tomography [13], estimates of fat distribution in different body regions support the concept that an increased waist-hip circumference ratio (upper-body obesity or hypertrophic obesity) shows a preponderance of fat in the abdominal region. This specific type of obesity, in contrast to subjects having low waist-hip circumference ratios (lower-body obesity or hyperplastic obesity), is associated with increased risk of hypertension, impaired glucose tolerance, and hyperinsulinemia [14–17]. This finding is true across race and gender groups and is independent of age [16, 17].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kannel W, Brand N, Skinner J, Dawber J, MacNamera P (1976): Relation of adiposity of blood pressure and development of hypertension: The Framingham Study. Ann Intern Med 68: 48–59.
Stamler R, Stamler J, Riedlinger WE, Algera G, Roberts RH (1978): Weight and blood pressure findings in hypertension screening of a million Americans. J Am Med Assoc 240: 1607–1610.
Epstein FM (1965): Prevalence of chronic disease and distribution of selected physiological variables in a total community of Tecumseh, Michigan. Am J Epidemiol 81: 307–322.
Levi RL, White PD, Stroud WD (1946): Overweight: A prognostic significance in relation to hypertension and cardiovascular-renal diseases. J Am Med Assoc 131: 951–953.
Hsu PH, Mathewson FAL, Rabkin SW (1977): Blood pressure and body mass index patterns a longitudinal study. J Chronic Dis 30: 93–113.
Rabkin SW, Mathewson FAL, Hsu PH (1977): Relation of body weight to development of ischemic heart disease in a cohort of young North American mean after a 26 year observation period: The Manitoba Study. Am J Cardiol 39: 452–458.
Goldring D, Londe S, Sivakoff M (1977): Blood pressure in a high school population standards for blood pressure and the relation of age, sex, weight, height and race to blood pressure in children 14 to 18 years of age. J Pediatr 91: 884–889.
Garn SM (1969): Relative fat patterning: An individual characteristic. Hum Biol 26: 75–89.
Edwards DAW (1950): Observations on the distribution of subcutaneous fat. Clin Sci 9: 259–270.
Vogue J (1956): The degree of masculine differentiation of obesities: A factor determining predisposition to diabetes, atherosclerosis, gout and uric calculus disease. Am J Clin Nutr 4: 20–34.
Albrink MJ, Meigs JW (1965): The relationship between serum triglycerides and skinfold thickness in obese subjects. Ann NY Acad Sci 131: 673–683.
Hartz AJ, Rupley D, Kalkhoff RK, Rimm AA (1983): Relationships of obesity to diabetes: Influence of obesity level and body fat distribution. Prev Med 12: 351–357.
Ashwell M, Cole TJ, Dixon AK (1985): Obesity new insight into the antropometric classification of fat distribution shown by computed tomography. BMJ 290: 1692–1694.
Berglund G, Ljungman S, Hartford M, Wilhemsen L, Bjorntorp P (1982): Type of obesity and blood pressure. Hypertension 4: 692–696.
Seidell JC, Bokx JC, Deboer R, Deurerberg P, Heutvast JGAJ (1985): Fat distribution of overweight persons in relation to morbidity and subjective health. Int J Obesity 9: 363–374.
Jarret RJ, Keen H, McCartney J, Fuller JH: Hamilton PJS, Reid DD, Rose G (1978): Glucose tolerance and blood pressure in two populations sample their relation to diabetes mellitus and hypertension. J Epidemiol 7: 15–34.
Butler WJ, Ostrander LD, Jr, Carmen WJ, Lamphlear DE, (1982): Diabetes mellitus in Tecumseh, Michigan: Prevalence in incidence and associated conditions. Am J Epidemiol 7:116, 971–980.
Reisin E, Abel R, Modan M, Silverberg DS, Eliahou HE, Modan B (1978): Effects of weight loss without salt restriction on the reduction of blood pressure. New Engl J Med 298: 1–5.
Gillum RF, Prineas RJ, Jeffery RW, Jacobs DR, Elmer PJ, Gomez O, Blackburn H (1983): Nonpharmacological therapy of hypertension: The independent effect of weight reduction and sodium restriction in overweight borderline hypertensive patients. Am Heart J 105: 128–133.
Tuck MJ, Sowers J, Dornfeld L, Kledzik G, Maxwell MH (1981): The effect of weight reduction on blood pressure, plasma renin activity and plasma aldosterone levels in obese patients. New Engl J Med 304: 12–13.
Reisin E, Frohlich ED (1982): Effects of weight reduction on arterial pressure. J Chronic Dis 35: 887–891.
Messerli FH, Christie B, DeCarvalho GR, Aristimuno GG, Suarez DH, Dreslinski GR, Frohlich ED (1981): Obesity and essential hypertension, intravascular volume, sodium excretion and plasma renin activity. Arch Intern Med 141: 81–85.
Hiramatzu K, Yamada T, Ichikawa K, Izumiyama T, Nagata H (1981): Changes in endocrine activities relative to obesity in patients with essential hypertension. J A Geriatr 29: 25–30.
Bull MB, Hillman RS, Cannon PJ, Laragh JH (1970): Renin and aldosterone secretion in man as influenced by changes in electrolyte balance and blood volume. Circ Res 27: 953–960.
Rocchini AP, Katch VL, Grekin R, Moorehead C, Anderson J (1986): Role for aldosterone in blood pressure regulation of obese adolescents. Am J Cardiol 57: 613–617.
Scavo D, Borgia C, Isacobelli A (1968): Aspetti di funzione corticosurenalica nell obesita Nota VI, II: Comportamento della secrezione di aldosterone e della escrezione dei suoi metabolite nel corso di alcune prove dinamiche. Folia Endocrinol 21: 591–602.
Kalkroff RK, Hartz AH, Rupley D, Kissebah AH, Kelber S (1983): Relationship of body fat distribution to blood pressure, carbohydrate tolerance and plasma lipids in healthy obese women. J Lab Clin Med 621–627.
Migeon CJ, Green OC, Eckert JP (1963): Study of adrenocortical function in obesity. Metabolism 12: 718–739.
Prezio JA, Carreon G, Clerkin E, Meloni CR, Kyle LH, Canary JJ (1964): Influence of body composition on adrenal function in obesity. J Clin Endocr Metab 24: 481–485.
Modan M. Halkin H, Almog S, Lusky A, Eshkol A, Shefi M (1985): Hyperinsulinemia: A link between hypertension obesity and glucose intolerance. J Clin Invest 75: 809–817.
Lopez A, Kerhl WA (1967): A possible interrelation between glucose-6-phosphate dehydrogenose and dehydroepiondrosterone in obesity. Lancet 1967/2: 485–487.
Evans DJ, Hoffman RG, Kalkhoff RK, Kissebah AH (1983): Relationship of adrogenic activity to body fat topography, fat cell morphology, and metabolic aberrations in premenopausal women. J Clin Endocr Metab 57: 304–310.
Hediger ML, Katz SH (1986): Fat patterning, overweight, and adrenal androgen interactions in black adolescent females. Hum Biol 58: 985–600.
Landsberg L, Young JB (1978): Fasting, feeding and regulation of the sympathetic nervous system. New Eng J Med 298: 1295–1301.
Young JB, Landsberg L (1982): Diet induced changes in sympathetic nervous system activity, possible implication for obesity and hypertension. J Chronic Dis 35: 879–886.
Young JB, Landsberg L (1977): Catecholamines and intermediary metabolism. J Clin Endocrinol Metabol 6: 559–631.
Danforth JE, Horton ES, O’Connell M, Sims EAH, Burger AG, Ingbar SH, Braverman L, Vagenakis AG (1979): Dietary induced alterations in thyroid hormone metabolism during overnutrition. J Clin Invest 64: 136–1347.
Sims EAH (1982): Mechanisms of hypertension in the overweight. Hypertension 4(Suppl III): III 43–III 49.
Sowers JR, Whitfield LA, Catania RA, Stern N, Tuck ML, Dornfeld L, Maxwell M (1982): Role of the sympathetic nervous system in blood pressure maintenance in obesity. J Clin Endocrinol Metabol 54: 1181–1186.
Boehringer K, Beretta Picoli C, Weidmann P, Meier A, Ziegler W (1982): Pressor factors and cardiovascular pressor responsiveness in lean and overweight normal or hypertensive subjects. Hypertension 4: 697–708.
Pickering G (1980): Salt intake and essential hypertension. Circ Reviews & Reports 1: 13–17.
Tobian L (1979): The relationship of salt to hypertension. Am J Clin Nutr 32: 2739–2748.
Page LB, Danion A, Moellerung Jr RC (1974): Antecedents of cardiovascular disease in six Solomon Island Societies. Circulation 49: 1132–1146.
Takahashi E, Sasaki N, Takeda J, Ito H (1957): The geographic distribution of cerebral hemorrhage and hypertension in Japan. Hum Biol 29: 130–166.
Dahl KK, Silver L, Christie RW (1958): Role of salt in the fall of blood pressure accompanying reduction of obesity. New Engl J Med 258: 1186–1192.
Tobian L (1978): Salt and hypertension. Ann NY Acad Sci 304: 178–202.
DeChamplain J (1977): The sympathetic system in hypertension. J Clin Endocrinol Metabol 6: 633–655.
Cole FE, Frohlich ED, MacPhee AA (1978): Angiotensin binding affinity and capacity in the midbrain area of spontaneously hypertensive and normotensive rats. Brain Res 154: 178–181.
Garay RP, Meyer P (1979): A new test showing abnormal net Na+ and K+ ATPase in erythrocytes of essential hypertensive patients. Lancet 1979/1: 349–353.
Avenell A, Leeds AR (1981): Sodium intake, inhibition of Na+-K+-ATPase and obesity. Lancet 1981/1: 836.
Whittman R, Blond DM (1965): Respiratory control by an adenosine triphosphatase involved in active transport in brain cortex. Biochem J 92: 117–158.
DeLuise M, Blackburn GL, Flier JS (1980): Reduced activity in the red cell sodium-potassium pump in human obesity. New Engl J Med 303: 1017–1022.
Klimes I, Nagulesparan M, Unger RH, Aronoff SL, Mott DM (1982): Decreased Na+-K+-ATPase activity in erythrocyte membranes and intact erythrocytes from obese men. J Clin Endocrinol 54: 721–724.
Mir MA, Charalambons BM, Morgan K, Evans PJ (1981): Erythrocyte sodium-potassium-ATPase and sodium transport in obesity. New Engl J Med 305:: 1264–1261.
Blaustein MP (1977): Sodium ions, calcium ions, blood pressure regulation and hypertension: A reassessment and a hypothesis. Am J Physiol 232: C-165–173.
Baumgart AV, Zidek W, Losse H, Karoff C, Wehling M, Vetter W, Vetter H (1983): Obesity, hypertension and intracellular electrolytes. Klin Wochenschr 6: 803–805.
Bjorntorp P (1986): Hypertension and other complications in human obesity. J Clin Hypertension 2: 163–165.
Krotkiewski M, Bjorntorp P, Sjostrom L, Smith V (1983): Impact of obesity on metabolism in men and women: Importance of regional adipose tissue distribution. J Clin Invest 72: 1150–1162.
DeFronzo RA, Cooke CR, Andres R, Faloona GR, Davis PJ (1975): The effect of insulin or renal handling of sodium, potassium, calcium and phosphate in man. J Clin Invest 55: 845–855.
Voors AW, Webber LS, Frerichs RR, Berenson GS (1981): Body height and body mass as determinants of basal blood pressure in children: The Bogalusa Heart Study. Am J Epidemiol 106: 101–108.
Winquist RJ, Webb RC, Bohr DF (1982): Vascular smooth muscle in hypertension. Fed Proc Am Soc Exp Biol 41: 2386–2393.
Christensen NJ (1983): Acute effects of insulin on cardiovascular function and noradrenaline uptake and release. Diabetologia 25: 377–381.
Friedman SM (1983): Monovalent and divalent ions in vascular tissue. Ann Intern Med 98: 753–758.
Alexander JK (1963): Obesity and the circulation. Mod Cardiovasc Dis 32: 799–803.
Alexander JK, Dennis EW, Smith WG, Amad KH, Austin RC (1963): Blood volume, cardiac output and distribution of systemic blood flow in extreme obesity. Cardiovasc Res Cent Bull, Suppl II: 39–44.
Backman L, Freyschuss V, Hollberg D, Melcher A (1973): Cardiovascular function in extreme obesity. Acta Med Scand 193: 437–446.
Knopp TR (1983): A methodological critique of the ‘ideal weight’ concept. J Am Med Assoc 250: 506–510.
Reisin E, Frohlich ED (1986): Hemodynamics in obesity, in: Zanchetti A, Tarazi RC (eds), Handbook of Hypertension, Vol 7: Pathophysiology of hypertension. Cardiovascular aspects, p. 281. Amsterdam: Elsevier Science Publishers.
Tarazi RC, Dustan HP, Frohlich ED, Gifford Jr RW, Hoffman GC (1970): Plasma volume and chronic hypertension relationship to arterial pressure levels in different hypertensive diseases. Arch Intern Med 125: 835–842.
Raison J, Achimastos A, Bouthier, London G, Safar M (1983): Intravascular volume, extracellular fluid volume and total body water in obese and nonobese hypertensive patients. Am J Cardiol 51: 165–170.
Raison J, Achimastos A, Asmar R, Simon A, Safar M (1986): Extracellular and interstitial fluid volume in obesity with and without associated systemic hypertension. Am J Cardiol 57: 223–226.
Alexander JK, Amad KH, Cole VW (1962): Observations on some clinical features of extreme obesity, with particular reference to cardiorespiratory effects. Am J Med 32: 512–523.
Frohlich ED, Messerli FH, Reisin E, Dunn FG (1983): The problem of obesity and hypertension. Hypertension 5(suppl III): III 71–III 78.
Toto-Moukouo JJ, Achimastos A, Asmar RG, Hughes CJ, Safar ME (1986): Pulse wave velocity in patients with obesity and hypertension. Am Heart J 21: 136–140.
Mujais SK, Tarazi RC, Dustan HP, Fouad FM, Bravo EL (1982): Hypertension in obese patients hemodynamic and volume studies. Hypertension 4: 84–92.
Dustan HP (1983): Mechanisms of hypertension associated with obesity. Ann Intern Med 98: 860–864.
Messerli FH, Sundgaard-Riise K, Reisin E, Dreslinski GR, Dunn FG, Frohlich ED (1983): Disparate cardiovascular effects of obesity and essential hypertension. Am J Med 74: 808–812.
Messerli FH, Sundgaard-Riise K, Reisin E, Dreslinski GR, Ventura HO, Oigman W, Frohlich ED, Dunn FG (1983): Dimorphic cardiac adaptation to obesity and arterial hypertension. Ann Intern Med 99: 757–761.
Reisin E, Messerli FH, Ventura HO, Frohlich ED (1987): Renal hemodynamic studies in obesity-hypertension. J Hypertension 5: 397–400.
Barret-Connor E, Kow KT (1985): Is hypertension more benign when associated with obesity? Circulation 72: 53–60.
MacMahon SW, Bernstein L, MacDonald GS, Andrew SG, Blacket RB (1985): Comparison of weight reduction with metoprolol in treatment of hypertension in young overweight patients. Lancet 1985/1: 1233–1250.
Cohen N, Flamenbaum W (1985): Obesity and hypertension. Demonstration of a ‘floor effect’. Am J Med 80: 177–181.
Dornfeld LP, Maxwell MH, Waks AV, Schroth P, Tuck ML (1985): Obesity and hypertension: Long-term effect of weight reduction on blood pressure. Int J Obesity 9: 381–389.
Reisin E (1986): Weight reduction in the management of hypertension: Epidemiologic and mechanistic evidence. Can J Physiol Pharmacol 64: 818–824.
Sowers JA, Nyby M, Naftali BS, Beck F, Baron S, Catania R, Vlachis N (1983): Blood pressure and hormone changes associated with weight reduction in the obese. Hypertension 4: 686–691.
Kolanowski J (1981): Influence of insulin and glucagon on sodium balance in obese subjects during fasting and refeeding. Int J Obesity 5: 5105–5114.
Weder AB, Toneti BA, Skatch VL, Rochini AP (1984): The antihypertensive effect of caloric restriction in obese adolescents: Dissociation of effect on erythrocyte countertransport and cotransport. J Hypertension 2: 507–514.
Boulter PR, Spark RF, Arky RA (1973): Dissociation of the renin aldosterone system and refractoriness to the sodium-retaining action of minerolocorticoid during starvation in man. J Clin Exp Metab 38: 248–254.
Marks P, Wilson B, Delasalle A (1985): Aldosterone studies in obese patients with hypertension. Am J Med Sci 289: 224–228.
Garnett ES, Cohen H, Nehmias C, Viol G (1973): The roles of carbohydrate, renin and aldosterone in sodium retention during and after total starvation. Metabolism 22: 867–874.
Reisin E, Frohlich ED, Messerli FH, Dreslinski GR, Dunn FG, Jones MM, Batson HM Jr (1983): Cardiovascular changes after weight reduction in obesity hypertension. Ann Intern Med 98: 315–319.
Shetty PS, Jung RT, James WPT (1979): Effect of catecholamine replacement with levodopa on the metabolic response to semistarvation. The Lancet 1979/1: 77–79.
Alexander JK, Peterson KL (1972): Cardiovascular effects of weight reduction. Circulation 69: 310–318.
Backman L, Freyschuss V, Hallberg D, Melcher A (1979): Reversibility of cardiovascular changes in extreme obesity: Effects of weight reduction through Yeyunoicleostomy. Acta Med Scand 205: 367–373.
Achimastos A, Raison J, Levenson J, Safar M (1984): Adipose tissue cellularity and hemodynamic indexes in obese patients with hypertension. Arch Intern Med 144: 265–268.
Young JB, Landsberg L (1977): Stimulation of the sympathetic nervous system during sucrose feeding. Nature 269: 615–617.
Jung RT, Shetty PS, Barrand M (1979): Role of catecholamine in hypotensive response to dieting. Br Med J 1: 12–13.
MacGregor GA, Best FE, Conn JM, Markandu ND, Elder DM, Sagnella GA, Squires M (1982): Double blind randomized crossover trial of moderate sodium restriction in essential hypertension. Lancet 1982/1: 351–354.
Sowers JR, Whitfield LA, Beck IWJ, Catania RA, Tuck ML, Donfeld L, Maxwell M (1982): Role of enhanced sympathetic nervous system activity and reduced Na-K dependent adenosine triphosphatose activity in maintenance of elevated blood pressure in obesity: Effect of weight loss. Clin Sci 63: 1215–1245.
Bogardus C, Ravussin E, Robbins DC, Wolfe RR, Horton ES, Sims EAH (1984): Effects of physical training and diet therapy on carbohydrate metabolism in patients with glucose intolerance and noninsulin dependent diabetes. Mellitus Diabetes 33: 311–318.
Grey N, Kipinis DM (1971): Effect of diet composition on the hyperinsulinemia of obesity. New Engl J Med 385: 827–831.
MacMahon SW, Wilcken DEL, MacDonald GJ (1986): The effect of weight reduction on left ventricular mass: A randomized controlled trial in young overweight hypertensive patients. New Engl J Med 314: 334–339.
Keys A, Henschel A, Taylor HL (1947): The size and function of the human heart at rest in semi-starvation and in subsequent rehabilitation. Am J Physiol 150: 153–169.
Page IH (1987): The Mosaic Theory, in: Hypertension Mechanisms, p. 914. Grune Stratton, Inc.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Kluwer Academic Publishers
About this chapter
Cite this chapter
Reisin, E., Frohlich, E.D. (1989). Hemodynamics in patients with overweight and hypertension. In: Safar, M.E., Fouad-Tarazi, F. (eds) The Heart in Hypertension. Developments in Cardiovascular Medicine, vol 98. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0941-0_11
Download citation
DOI: https://doi.org/10.1007/978-94-009-0941-0_11
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6913-7
Online ISBN: 978-94-009-0941-0
eBook Packages: Springer Book Archive